Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80,437,135
-
Number of holders
-
174
-
Total 13F shares, excl. options
-
73,830,496
-
Shares change
-
+365,896
-
Total reported value, excl. options
-
$3,120,577,918
-
Value change
-
+$3,824,478
-
Put/Call ratio
-
52%
-
Number of buys
-
96
-
Number of sells
-
-84
-
Price
-
$42.27
Significant Holders of PTC THERAPEUTICS, INC. - Common Stock (PTCT) as of Q2 2021
222 filings reported holding PTCT - PTC THERAPEUTICS, INC. - Common Stock as of Q2 2021.
PTC THERAPEUTICS, INC. - Common Stock (PTCT) has 174 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 73,830,496 shares
of 80,437,135 outstanding shares and own 91.79% of the company stock.
Largest 10 shareholders include FMR LLC (10,568,386 shares), WELLINGTON MANAGEMENT GROUP LLP (8,731,392 shares), VANGUARD GROUP INC (6,734,630 shares), BlackRock Inc. (6,519,367 shares), FRANKLIN RESOURCES INC (5,789,994 shares), RTW INVESTMENTS, LP (5,293,966 shares), JANUS HENDERSON GROUP PLC (3,503,914 shares), STATE STREET CORP (2,377,027 shares), PRICE T ROWE ASSOCIATES INC /MD/ (2,112,668 shares), and ARMISTICE CAPITAL, LLC (2,092,000 shares).
This table shows the top 174 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.